Symbicort is now FDA approved for COPD

The FDA has approved the use of Symbicort (budesonide/formoterol) for the treatment of COPD. Symbicort is a combination inhaler that was originally approved for the treatment of asthma and is manufactured by AstraZeneca. Like many other new drugs, it has been available in Europe for a while now.